The new SpaceOAR Vue Hydrogel is an absorbable hydrogel spacer designed to protect your patient’s rectum by minimising negative radiation side effects during prostate cancer treatment. It is safe, easily injectable and visible on CT scan, intended to improve contouring accuracy and to potentially optimise treatment planning. See how it works and connect with global experts during the virtual launch event.
Why Hydrogel Spacing?
Radiotherapy is a well-established curative treatment for patients with prostate cancer. A prostate cancer patient who undergoes radiotherapy will potentially suffer from side effects due to radiation which may impact his quality of life. SpaceOAR Vue Hydrogel is a hydrogel spacer designed to temporarily position the anterior rectal wall away from the prostate, reducing the radiation dose delivered to the rectum during prostate cancer radiation therapy.
SpaceOAR Vue Hydrogel is a notable innovation compared to SpaceOAR™ Hydrogel since it offers enhanced visibility on CT scan. This allows you to contour the prostate more accurately and position your patients more consistently for radiotherapy. It reduces the need for an MRI scan, streamlining workflows across your department. SpaceOAR Vue Hydrogel may help you offer your patients safer, more efficient and more effective treatment planning, increasing the chances for a higher quality of life during and after radiation therapy.
Dr. Sean Collins
Dr. Elisha Fredman
Dr. Preston Sprenkle
Prof. Heather Payne
"My greatest hope is that it
would be available to all
Henry, SpaceOAR patient, USA
1. Mariados N, Sylvester J, Shah D, et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-7.
Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.
SpaceOAR and SpaceOAR Vue Hydrogels are intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR and SpaceOAR Vue Hydrogels to reduce the radiation dose delivered to the anterior rectum. As with any medical treatment, there are some risks involved with the use of SpaceOAR and SpaceOAR Vue Hydrogels. Potential complications associated with SpaceOAR and SpaceOAR Vue Hydrogels include, but are not limited to: pain associated with SpaceOAR and SpaceOAR Vue Hydrogels injection; pain or discomfort associated with SpaceOAR and SpaceOAR Vue Hydrogels; needle penetration of the bladder, prostate, rectal wall, rectum or urethra; injection of SpaceOAR and SpaceOAR Vue Hydrogels into the bladder, prostate, rectal wall, rectum or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR and SpaceOAR Vue Hydrogels intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; and rectal urgency.
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.